Bartusik-Aebisher D

2026

The Influence of Molecular Factors on the Effectiveness of New Therapies in Endometrial Cancer-Latest Evidence and Clinical Trials.

Cancers ·doi:10.3390/cancers18030356

Endometrial cancer (EC) is the most common gynecological cancer in developed countries, with approximately 417,000 new cases reported worldwide in 2020. Its incidence has been rising for the past 30 years, primarily due to population aging,…

2025

The Medical Basis for the Photoluminescence of Indocyanine Green.

Molecules (Basel, Switzerland) ·doi:10.3390/molecules30040888

Indocyanine green (ICG), a near-infrared (NIR) fluorescent dye with unique photoluminescent properties, is a helpful tool in many medical applications. ICG produces fluorescence when excited by NIR light, enabling accurate tissue visualizat…

2024

Photodynamic Therapy in the Treatment of Cancer-The Selection of Synthetic Photosensitizers.

Pharmaceuticals (Basel, Switzerland) ·doi:10.3390/ph17070932

Photodynamic therapy (PDT) is a promising cancer treatment method that uses photosensitizing (PS) compounds to selectively destroy tumor cells using laser light. This review discusses the main advantages of PDT, such as its low invasiveness…

2024

The Use of Photodynamic Therapy in the Treatment of Endometrial Cancer-A Review of the Literature.

International journal of molecular sciences ·doi:10.3390/ijms25168772

Endometrial cancer is the most common malignant tumor of the female reproductive system. It develops in the mucous membrane lining the inside of the uterine body-the endometrium, through the abnormal and continuous growth of cancer cells or…